Role of death receptor and mitochondrial pathways in conventional chemotherapy drug induction of apoptosis

Peng Wang, Jin H. Song, Doyoun K. Song, Jing Zhang, Chunhai Hao

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

The molecular mechanism underlying chemotherapy-induced apoptosis is often debated because of contradicting reports of its signaling pathway. The focus of this ongoing debate is on the requirement of a death receptor and its role in subsequent activation of caspase-8. Understanding the precise mechanism responsible for apoptosis and identifying molecules targeted by chemotherapy will allow us to develop better therapeutic strategies that target the inherent abnormalities of cancer cells. To show conventional chemotherapy drugs can trigger the caspase cascade, including caspase-8, -9, -3 and DNA fragmentation factor, Jurkat T leukemia cells were treated with cisplatin or etoposide in a dose-dependent and a time-dependent manner. Cisplatin and etoposide all induced apoptosis in wild-type Jurkat T leukemia cells. On the other hand, when a pan-caspase inhibitor zVAD-FMK was pretreated, apoptosis did not occur, indicating that these chemotherapy drugs mediated caspase-dependent apoptosis. However, the chemotherapy drug induction of apoptosis was not inhibited by treatment of zIETD-FMK, a caspase-8 inhibitor. There was no difference in cell death between wild-type and caspase-8 or FADD-deficient Jurkat cells after treatment of chemotherapy drug. In addition, cisplatin-induced apoptosis is abrogated by the overexpression of either Bcl-2 or Bcl-xL, which diminished changes of mitochondrial membrane potential and decreased the amount of cytochrome c released from mitochondria. Again, cisplatin-induced apoptosis was not diminished by c-FLIP-overexpression, whereas the c-FLIP-overexpressing cells were less sensitive to TRAIL-induced apoptosis than the wild type cells. Therefore, these results indicate that conventional chemotherapy drug-triggered apoptosis is indispensable, and its pathway is independent of the death receptor.

Original languageEnglish (US)
Pages (from-to)1528-1535
Number of pages8
JournalCellular Signalling
Volume18
Issue number9
DOIs
StatePublished - Sep 1 2006
Externally publishedYes

Fingerprint

Death Domain Receptors
Induction Chemotherapy
Apoptosis
Pharmaceutical Preparations
Caspase 8
Drug Therapy
Cisplatin
T-Cell Leukemia
Caspase Inhibitors
Etoposide
Caspases
Jurkat Cells
Caspase 9
Mitochondrial Membrane Potential
DNA Fragmentation
Cytochromes c
Mitochondria
Cell Death
Therapeutics

Keywords

  • Apoptosis
  • Caspase
  • Death receptor
  • DNA damage
  • Mitochondria

ASJC Scopus subject areas

  • Cell Biology

Cite this

Role of death receptor and mitochondrial pathways in conventional chemotherapy drug induction of apoptosis. / Wang, Peng; Song, Jin H.; Song, Doyoun K.; Zhang, Jing; Hao, Chunhai.

In: Cellular Signalling, Vol. 18, No. 9, 01.09.2006, p. 1528-1535.

Research output: Contribution to journalArticle

Wang, Peng ; Song, Jin H. ; Song, Doyoun K. ; Zhang, Jing ; Hao, Chunhai. / Role of death receptor and mitochondrial pathways in conventional chemotherapy drug induction of apoptosis. In: Cellular Signalling. 2006 ; Vol. 18, No. 9. pp. 1528-1535.
@article{ad2f042632cc45ef9cb01e1aab3fdd17,
title = "Role of death receptor and mitochondrial pathways in conventional chemotherapy drug induction of apoptosis",
abstract = "The molecular mechanism underlying chemotherapy-induced apoptosis is often debated because of contradicting reports of its signaling pathway. The focus of this ongoing debate is on the requirement of a death receptor and its role in subsequent activation of caspase-8. Understanding the precise mechanism responsible for apoptosis and identifying molecules targeted by chemotherapy will allow us to develop better therapeutic strategies that target the inherent abnormalities of cancer cells. To show conventional chemotherapy drugs can trigger the caspase cascade, including caspase-8, -9, -3 and DNA fragmentation factor, Jurkat T leukemia cells were treated with cisplatin or etoposide in a dose-dependent and a time-dependent manner. Cisplatin and etoposide all induced apoptosis in wild-type Jurkat T leukemia cells. On the other hand, when a pan-caspase inhibitor zVAD-FMK was pretreated, apoptosis did not occur, indicating that these chemotherapy drugs mediated caspase-dependent apoptosis. However, the chemotherapy drug induction of apoptosis was not inhibited by treatment of zIETD-FMK, a caspase-8 inhibitor. There was no difference in cell death between wild-type and caspase-8 or FADD-deficient Jurkat cells after treatment of chemotherapy drug. In addition, cisplatin-induced apoptosis is abrogated by the overexpression of either Bcl-2 or Bcl-xL, which diminished changes of mitochondrial membrane potential and decreased the amount of cytochrome c released from mitochondria. Again, cisplatin-induced apoptosis was not diminished by c-FLIP-overexpression, whereas the c-FLIP-overexpressing cells were less sensitive to TRAIL-induced apoptosis than the wild type cells. Therefore, these results indicate that conventional chemotherapy drug-triggered apoptosis is indispensable, and its pathway is independent of the death receptor.",
keywords = "Apoptosis, Caspase, Death receptor, DNA damage, Mitochondria",
author = "Peng Wang and Song, {Jin H.} and Song, {Doyoun K.} and Jing Zhang and Chunhai Hao",
year = "2006",
month = "9",
day = "1",
doi = "10.1016/j.cellsig.2005.12.004",
language = "English (US)",
volume = "18",
pages = "1528--1535",
journal = "Cellular Signalling",
issn = "0898-6568",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - Role of death receptor and mitochondrial pathways in conventional chemotherapy drug induction of apoptosis

AU - Wang, Peng

AU - Song, Jin H.

AU - Song, Doyoun K.

AU - Zhang, Jing

AU - Hao, Chunhai

PY - 2006/9/1

Y1 - 2006/9/1

N2 - The molecular mechanism underlying chemotherapy-induced apoptosis is often debated because of contradicting reports of its signaling pathway. The focus of this ongoing debate is on the requirement of a death receptor and its role in subsequent activation of caspase-8. Understanding the precise mechanism responsible for apoptosis and identifying molecules targeted by chemotherapy will allow us to develop better therapeutic strategies that target the inherent abnormalities of cancer cells. To show conventional chemotherapy drugs can trigger the caspase cascade, including caspase-8, -9, -3 and DNA fragmentation factor, Jurkat T leukemia cells were treated with cisplatin or etoposide in a dose-dependent and a time-dependent manner. Cisplatin and etoposide all induced apoptosis in wild-type Jurkat T leukemia cells. On the other hand, when a pan-caspase inhibitor zVAD-FMK was pretreated, apoptosis did not occur, indicating that these chemotherapy drugs mediated caspase-dependent apoptosis. However, the chemotherapy drug induction of apoptosis was not inhibited by treatment of zIETD-FMK, a caspase-8 inhibitor. There was no difference in cell death between wild-type and caspase-8 or FADD-deficient Jurkat cells after treatment of chemotherapy drug. In addition, cisplatin-induced apoptosis is abrogated by the overexpression of either Bcl-2 or Bcl-xL, which diminished changes of mitochondrial membrane potential and decreased the amount of cytochrome c released from mitochondria. Again, cisplatin-induced apoptosis was not diminished by c-FLIP-overexpression, whereas the c-FLIP-overexpressing cells were less sensitive to TRAIL-induced apoptosis than the wild type cells. Therefore, these results indicate that conventional chemotherapy drug-triggered apoptosis is indispensable, and its pathway is independent of the death receptor.

AB - The molecular mechanism underlying chemotherapy-induced apoptosis is often debated because of contradicting reports of its signaling pathway. The focus of this ongoing debate is on the requirement of a death receptor and its role in subsequent activation of caspase-8. Understanding the precise mechanism responsible for apoptosis and identifying molecules targeted by chemotherapy will allow us to develop better therapeutic strategies that target the inherent abnormalities of cancer cells. To show conventional chemotherapy drugs can trigger the caspase cascade, including caspase-8, -9, -3 and DNA fragmentation factor, Jurkat T leukemia cells were treated with cisplatin or etoposide in a dose-dependent and a time-dependent manner. Cisplatin and etoposide all induced apoptosis in wild-type Jurkat T leukemia cells. On the other hand, when a pan-caspase inhibitor zVAD-FMK was pretreated, apoptosis did not occur, indicating that these chemotherapy drugs mediated caspase-dependent apoptosis. However, the chemotherapy drug induction of apoptosis was not inhibited by treatment of zIETD-FMK, a caspase-8 inhibitor. There was no difference in cell death between wild-type and caspase-8 or FADD-deficient Jurkat cells after treatment of chemotherapy drug. In addition, cisplatin-induced apoptosis is abrogated by the overexpression of either Bcl-2 or Bcl-xL, which diminished changes of mitochondrial membrane potential and decreased the amount of cytochrome c released from mitochondria. Again, cisplatin-induced apoptosis was not diminished by c-FLIP-overexpression, whereas the c-FLIP-overexpressing cells were less sensitive to TRAIL-induced apoptosis than the wild type cells. Therefore, these results indicate that conventional chemotherapy drug-triggered apoptosis is indispensable, and its pathway is independent of the death receptor.

KW - Apoptosis

KW - Caspase

KW - Death receptor

KW - DNA damage

KW - Mitochondria

UR - http://www.scopus.com/inward/record.url?scp=33744800048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744800048&partnerID=8YFLogxK

U2 - 10.1016/j.cellsig.2005.12.004

DO - 10.1016/j.cellsig.2005.12.004

M3 - Article

VL - 18

SP - 1528

EP - 1535

JO - Cellular Signalling

JF - Cellular Signalling

SN - 0898-6568

IS - 9

ER -